Compounds > bd 1047
Page last updated: 2024-09-05

bd 1047 and sm 346

bd 1047 has been researched along with sm 346 in 4 studies

Compound Research Comparison

Studies
(bd 1047)		Trials
(bd 1047)		Recent Studies (post-2010)
(bd 1047)		Studies
(sm 346)		Trials
(sm 346)		Recent Studies (post-2010) (sm 346)
118054129857

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Behensky, A; Cuevas, J; Katnik, C; Rodriguez, A1
Behensky, A; Cuevas, J; Deng, W; Katnik, C1
Kadnikov, IA; Seredenin, SB; Voronin, MV; Voronkov, DN1
Kadnikov, IA; Seredenin, SB; Verbovaya, ER; Voronin, MV; Voronkov, DN1

Other Studies

4 other study(ies) available for bd 1047 and sm 346

ArticleYear
Afobazole modulates microglial function via activation of both sigma-1 and sigma-2 receptors.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 339, Issue:1

    Topics: Adenosine Triphosphate; Animals; Anti-Anxiety Agents; Benzimidazoles; Brain Ischemia; Butyrates; Calcium; Cell Death; Cell Survival; Ethylenediamines; Female; Membrane Potentials; Microglia; Morpholines; Patch-Clamp Techniques; Piperazines; Pregnancy; Purinergic P2X Receptor Antagonists; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sigma-1 Receptor; Tropanes; Uridine Triphosphate

2011
Afobazole modulates neuronal response to ischemia and acidosis via activation of sigma-1 receptors.
    The Journal of pharmacology and experimental therapeutics, 2011, Volume: 339, Issue:1

    Topics: Acidosis; Animals; Anti-Anxiety Agents; Benzimidazoles; Brain Ischemia; Calcium; Cell Survival; Cerebral Cortex; Ethylenediamines; Female; Guanidines; Indicators and Reagents; L-Lactate Dehydrogenase; Membrane Potentials; Morpholines; Narcotics; Neurons; Patch-Clamp Techniques; Pentazocine; Phencyclidine; Piperazines; Pregnancy; Rats; Receptors, sigma; Sigma-1 Receptor

2011
Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease.
    Scientific reports, 2019, 11-19, Volume: 9, Issue:1

    Topics: Animals; Benzimidazoles; Corpus Striatum; Disease Models, Animal; Dopamine; Ethylenediamines; Male; Mice; Mice, Inbred ICR; Morpholines; Neurons; Neuroprotection; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptors, sigma; Rotarod Performance Test; Sigma-1 Receptor; Substantia Nigra

2019
Deferred Administration of Afobazole Induces Sigma1R-Dependent Restoration of Striatal Dopamine Content in a Mouse Model of Parkinson's Disease.
    International journal of molecular sciences, 2020, Oct-15, Volume: 21, Issue:20

    Topics: Animals; Benzimidazoles; Corpus Striatum; Dopamine; Ethylenediamines; Male; Mice; Mice, Inbred ICR; Morpholines; Movement; Parkinson Disease; Receptors, sigma; Sigma-1 Receptor

2020